Export

EN
FR
ATC codes: J01XA01
EMLc
Indication
Endophthalmitis ICD11 code: 9C21
INN
Vancomycin
Medicine type
Chemical agent
Antibiotic groups
List type
Core (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 250 mg in vial (as hydrochloride) powder for injection
EML status history
First added in 2021 (TRS 1035)
Changed in 2023 (TRS 1049)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Expert Committee recommendation
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended: - the addition of a new strength formulation of ceftriaxone (powder for injection: 500 mg (as sodium) in vial) to the EML and EMLc. - the addition of new strength formulations of IV vancomycin (500 mg, 1 g (as hydrochloride) on the EMLc.
EML recommendations: Endophthalmitis
First choice
Second choice
First choice
ceftazidime co-prescribed with vancomycin
ceftriaxone co-prescribed with vancomycin
Second choice